ACRVAcrivon Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 11268
Ticker: ACRV
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2022-11-15
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ACRV

Detail

Enriched 2026-08-14 20:47

Market cap: $73,618,973.88
Shares outstanding (class): 42,801,729
Shares outstanding (weighted): 42,801,729
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 76
Location: WATERTOWN, MA
Homepage: https://www.acrivon.com
Description: Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.

Market cap and share counts drift.

Funds holding this security

8 funds · 8 positions · $1.29M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$758.3K	0.00%	545,541 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$245.3K	0.00%	176,494 NS	FIGI
Ultra-Small Company Fund Bridgeway Funds, Inc.	—	$161.2K	0.19%	116,000 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$62.8K	0.01%	45,169 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$52.8K	0.04%	38,000 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$5.0K	0.00%	3,569 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$3.3K	0.00%	2,400 NS	FIGI
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$1.1K	0.00%	802 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERACRV
FIGI_COMPOSITEBBG011RWR2Q4
FIGI_SHARE_CLASSBBG011RWR2R3
CIK0001781174
ISINUS0048901096
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock of a pharmaceutical company, classified under healthcare and pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.